Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019003053) ASSOCIATION COMPRISING OXYGEN AND HYALURONIC ACID FOR TOPICAL-VAGINAL USE.
Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

CLAIMS

1. An association comprising molecular oxygen and hyaluronic acid for use in topical treatment of vaginal disorders.

2. The association for use according to claim 1, wherein said molecular oxygen has a purity degree between 80% and 97% (v/v).

3. The association for use according to claim 1 or 2, wherein oxygen is administered jointly with hyaluronic acid.

4. The association for use according to claim 3, wherein oxygen is administered prior to the combined administration with hyaluronic acid.

5. The association for use according to any one of claims 1 to 4, wherein hyaluronic acid has a molecular weight between 200 kDa and 2 MDa.

6. The association for use according to any one of claims 1 to 5, wherein molecular oxygen has a flow rate between 0.1 L/min and 5 L/min.

7. The association for use according to claim 6, wherein hyaluronic acid is in the form of salt of a biologically acceptable alkaline metal.

8. The association for use according to claim 7, wherein hyaluronic acid is in the form of sodium hyaluronate.

9. The association for use according to claim 8, wherein sodium hyaluronate is administered at a dosage between 10 mg and 100 mg out of a unit of volume of molecular oxygen.

10. The association for use according to claim 8, wherein sodium hyaluronate is administered together with said oxygen for a time ranging from 5 min to 15 min.

11. The association for use according to any one of claims 1 to 12, wherein said vaginal disorders are selected between vaginal dryness and vulvovaginal atrophy.